Argenx wants to get in on the macrocyclic peptide action, penning a deal worth $1.5 billion in biobucks with Californian ...

Snake, scorpion, and spider venom are most frequently associated with poisonous bites, but with the help of artificial ...

The Europe GLP-1 agonists market, valued at USD 7.09 billion in 2024, is set to grow at a 17.30% CAGR, reaching USD 14.34 billion by 2034. Driven by ...

Candidate Name: Julianne Gath Degree: Master's Defense Date: Monday, July 28, 2025 Time: 12:30 to 2:30 p.m. Location: Room 518, Olney Hall, North Campus Thesis Title: “Investigating Nanoscale ...

Tesamorelin, a synthetic growth hormone-releasing hormone (GHRH) analog, has garnered significant attention in scientific circles due to its intriguing properties. Studies suggest that the peptide ...

After nearly 15 years' research, scientists at the UdeM-affiliated CHU Sainte-Justine have developed a compound that has ...